▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2201 by analyst upside · 2026-06-27
LMAT
LeMaitre Vascular, Inc.
Healthcare · Market Cap $2B · P/E 34.5x
ANALYST PRICE TARGET
+24.1%
implied upside to consensus target
Current Price $95.66
Consensus Target $118.75
Bull Target $135.0
Bear Target $102.0
Analysts Covering 8
ANALYST CONSENSUS — BUY
Strong Buy
2
Buy
3
Hold
3
Sell
0
52-Week Low $79.01
52-Week High $118.01
YTD Return +19.9%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 34.5x
Forward P/E 29.4x
EPS (TTM) $2.77
PEG Ratio 2.56
Dividend Yield 1.05%
Revenue (TTM) $256M
Profit Margin 24.3%
52-WEEK RANGE
52-Week Low $79.01
52-Week High $118.01
Current Price $95.66
Bear Target $102.0
Bull Target $135.0
● Now $95.66 ● Target $118.75
TRADING DATA
Avg Volume 266K
YTD Return +19.9%
Analyst Count 8
Consensus Buy
Upside to Target +24.1%
Last Updated 2026-06-27

ANALYST SUMMARY

LeMaitre Vascular, Inc. (LMAT) is currently trading at $95.66 with a Wall Street consensus price target of $118.75, implying potential upside of 24.1% over the next 12 months. 8 analysts currently cover LMAT, with a consensus rating of Buy — 62% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $135.0, while the most cautious has a target of $102.0.

LMAT operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 19.9% year-to-date and is currently trading near the lower end of its 52-week range of $79.01 – $118.01.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

UFPT +24.9%
UFP Technologies, Inc.
$2B · P/E 29.6x · Underperform
PBH +35.2%
Prestige Consumer Healthcare Inc.
$2B · P/E 12.6x · Buy
ADUS +36.9%
Addus HomeCare Corporation
$2B · P/E 17.9x · Buy
SEM +0.8%
Select Medical Holdings Corporation
$2B · P/E 15.4x · Hold
HCSG +7.8%
Healthcare Services Group, Inc.
$2B · P/E 24.8x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for LMAT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research — Reiterated
Outperform → Outperform 2026-06-03 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-05-06 Building track record
Citizens — Reiterated
Market Outperform → Market Outperform 2026-05-06 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-05-06 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-02-26 Building track record
Roth Capital reit
Buy → Buy 2026-02-26 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-02-26 Building track record
Citizens — Reiterated
Market Outperform → Market Outperform 2026-02-26 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →